In 2007, Muto et al. found that emodin inhibited the growth of multiple myeloma (MM) cells and induced cell apoptosis by inhibiting Janus-activated kinase 2 (JAK2) activity and phosphorylation of STAT3 and downregulating Mcl-1 178. Here, MCL1 is linked to plasma cell myeloma.